Tryptanthrin (Indolo[2,1-b]quinazolin-6,12-dione)

Tryptanthrin (Indolo[2,1-b]quinazolin-6,12-dione) is a naturally occurring alkaloid found in plants such as Isatis tinctoria (woad) and Strobilanthes cusia, where it exerts anti-inflammatory and anticancer effects primarily by inhibiting inflammasome activation and suppressing tumor-promoting immune pathways. Its bioactivity centers on blocking NLRP3, NLRC4, and AIM2 inflammasome complexes, as well as reducing regulatory T cell populations in tumor microenvironments.

Origin & History

Tryptanthrin (indolo[2,1-b]quinazolin-6,12-dione) is a naturally occurring indole alkaloid isolated from traditional medicinal plants like Isatis indigotica (Isatidis Radix), historically used in Chinese medicine. It is obtained through extraction from plant materials followed by purification, with synthetic derivatives also commonly produced for research purposes.

Historical & Cultural Context

Tryptanthrin has a long history in traditional Chinese medicine, derived from Isatis indigotica (Isatidis Radix). It has been traditionally used for its antimicrobial properties spanning centuries in these medical systems.

Health Benefits

• Anti-inflammatory effects: Inhibits multiple inflammasomes (NLRP3, NLRC4, AIM2) in mouse models of NASH and sepsis (preliminary animal evidence)
• Cancer growth inhibition: Suppressed tumor growth and reduced regulatory T cells in Lewis lung cancer mouse models (preliminary animal evidence)
• Colorectal cancer suppression: Showed antiproliferative effects at 50-200 mg/kg in SW620 xenograft mice models (preliminary animal evidence)
• Immune system modulation: Acts as IDO-1 inhibitor, augmenting T-cell proliferation in cancer models (preliminary in vitro evidence)
• Antimicrobial activity: Demonstrates antibacterial, antifungal, antiprotozoal, and antiparasitic properties (traditional use, preliminary evidence)

How It Works

Tryptanthrin inhibits the assembly and activation of multiple inflammasome complexes—NLRP3, NLRC4, and AIM2—thereby reducing caspase-1 cleavage and downstream secretion of pro-inflammatory cytokines IL-1β and IL-18. It also suppresses the aryl hydrocarbon receptor (AhR) and COX-2-mediated prostaglandin E2 synthesis, attenuating both innate immune overactivation and tumor-supportive inflammation. In cancer models, tryptanthrin reduces CD4+CD25+FoxP3+ regulatory T cells within the tumor microenvironment, thereby partially restoring antitumor immune surveillance.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on tryptanthrin. All available evidence is limited to preclinical in vitro studies and animal models, including mouse models of NASH, sepsis, and various cancers.

Clinical Summary

The majority of evidence for tryptanthrin comes from in vitro cell studies and in vivo mouse models, with no large-scale human clinical trials published to date. In mouse models of non-alcoholic steatohepatitis (NASH), tryptanthrin administration significantly reduced hepatic inflammasome activation and fibrosis markers compared to untreated controls. In Lewis lung carcinoma mouse models, tryptanthrin treatment suppressed primary tumor growth and decreased intratumoral regulatory T cell frequency, though exact dosing and tumor volume reductions varied across studies. Overall, the evidence base remains preliminary and animal-derived; human pharmacokinetic and efficacy data are critically lacking.

Nutritional Profile

Tryptanthrin (Indolo[2,1-b]quinazolin-6,12-dione) is a bioactive alkaloid compound, not a nutrient or food source, so a traditional nutritional profile (macronutrients, vitamins, minerals, fiber, protein) is not applicable. Key chemical and bioactive details: • Molecular formula: C₁₅H₈N₂O₂; Molecular weight: 248.24 g/mol • Classification: Indoloquinazoline alkaloid; a fusion product of indole and quinazoline ring systems • Natural sources: Found in trace quantities in several medicinal plants including Polygonum tinctorium (Japanese indigo, leaves), Isatis tinctoria (woad, leaves and roots), Couroupita guianensis (cannonball tree), and Strobilanthes cusia; also produced by certain yeasts (Candida lipolytica) and bacteria • Typical concentrations in natural sources: Highly variable and generally low; in Isatis tinctoria root extracts (Ban Lan Gen), tryptanthrin is present at approximately 0.001–0.05% w/w depending on extraction method; in Polygonum tinctorium leaf extracts, concentrations range from ~0.01–0.1 mg/g dry weight • Bioavailability notes: Tryptanthrin is a lipophilic compound (LogP ~2.2–2.8) with moderate aqueous solubility (~poorly soluble in water, soluble in DMSO, ethanol, and chloroform); oral bioavailability in rodent models appears limited but sufficient for pharmacological activity at doses of 50–200 mg/kg; absorption is likely enhanced by lipid-based formulations; metabolism involves hepatic cytochrome P450-mediated oxidation and glucuronidation • Key bioactive mechanisms: Functions as a COX-2 inhibitor (IC₅₀ ~0.1–1 µM in cell-based assays), 5-lipoxygenase inhibitor, IκB kinase inhibitor suppressing NF-κB signaling, and inflammasome inhibitor (NLRP3, NLRC4, AIM2); also reported to inhibit indoleamine 2,3-dioxygenase (IDO) and tryptophan metabolism pathways relevant to immune modulation • No caloric value, no macronutrient content, no vitamin or mineral content — this is a pure pharmacologically active small molecule compound, not a food or dietary supplement ingredient in conventional use

Preparation & Dosage

No clinically studied human dosages are available. Animal studies used intraperitoneal doses of 50-200 mg/kg body weight in mice. In vitro studies tested concentrations of 12.5-100 μM. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Green tea extract, Resveratrol, Quercetin, Boswellia

Safety & Interactions

Human safety data for isolated tryptanthrin supplementation are extremely limited, and no established safe dosage range has been defined for human use. In rodent studies, tryptanthrin has been administered at doses ranging from approximately 10–50 mg/kg without reported acute toxicity, but this does not establish human safety. Because tryptanthrin modulates AhR signaling and cytochrome P450 enzymes (particularly CYP1A1 and CYP1A2), it may theoretically interact with drugs metabolized by these pathways, including certain antidepressants, antiarrhythmics, and chemotherapy agents. Tryptanthrin should be avoided during pregnancy and lactation due to complete absence of reproductive safety data.